Dementia with Lewy bodies

Sreenath, Sangahalli; Barber, Robert
May 2009
Clinical Risk;May2009, Vol. 15 Issue 3, p115
Academic Journal
This article will review the important clinical risks associated with dementia with Lewy bodies (DLB), the second commonest cause of neurodegenerative dementia in older people after Alzheimer's disease. The risks can be relatively specific to DLB, but as patients will also share many of the risks common to all types of dementia, both specific and generic risks will be summarized. Finally, the frequency and extent of NHS litigation claims as they relate to dementia are discussed.


Related Articles

  • Association between male gender and cortical Lewy body pathology in large autopsy series. Nelson, Peter T.; Schmitt, Frederick A.; Jicha, Gregory A.; Kryscio, Richard A.; Abner, Erin L.; Smith, Charles D.; Eldik, Linda J. Van; Markesbery, William R. // Journal of Neurology;Nov2010, Vol. 257 Issue 11, p1875 

    Sex-linked factors may alter risk for neurodegenerative diseases. Definitive diagnoses are not established until autopsy, so neuropathological studies are critical. There have not been reported gender-related differences in neocortical Lewy bodies (LBs) using large multi-center autopsy series....

  • Counting costs. Page, Sean // Nursing Standard;5/25/2005, Vol. 19 Issue 37, p24 

    Draft guidelines from the National Institute for Health and Clinical Excellence (NICE), currently out for consultation, have suggested that drugs for the treatment of Alzheimer's disease should not be prescribed on the NHS, If this becomes policy, much of the proactive work in dementia care...

  • UK High Court rules in NICE Aricept case.  // European Pharmaceutical Executive;Sep2007, p8 

    The article reports on a court ruling concerning the cost-effectiveness of the drug Aricept in treating Alzheimer's disease. Great Britain�s High Court ruled that the National Institute of Health and Clinical Excellence (NICE) review evidence, in order to determine the cost-effectiveness of...

  • NHS accused of zero funding awareness.  // Community Care;1/11/2007, Issue 1655, p11 

    The article reports that an Alzheimer's Society volunteer who won a long battle for continuing care funding for his mother has claimed awareness of the system is poor in the National Health Service (NHS). Mike Pearce said his experience of attempting to claim full care funding for his mother,...

  • NICE limits AD drug use.  // European Pharmaceutical Executive;Jul/Aug2006, p12 

    The article reports that the National Institute for Health and Clinical Excellence (NICE) has restricted patients who are newly diagnosed with Alzheimer's disease (AD) to have an access to drug treatment at the National Health Service in Great Britain. NICE also mandated that drugs like...

  • Campaigner court action to oppose Alzheimer drugs' ruling. Harrison, Sarah // Nursing Older People;Nov2006, Vol. 18 Issue 10, p5 

    The article focuses on issues related to medical care of older people in Great Britain. Campaigners are planning to file a lawsuit against Great Britain's National Health Service after the National Institute for Health and Clinical Excellence ruled that Alzheimer's drugs were high-priced. Older...

  • Transparency in health technology assessments. Maynard, Alan // BMJ: British Medical Journal (International Edition);3/24/2007, Vol. 334 Issue 7594, p594 

    This article discusses whether, in a challenge by the drug company, Shire, Great Britain's National Health Service National Institute for Health and Clinical Excellence (NICE) should make the contracted work of external academic assessment groups in modeling assumptions available in other than...

  • The importance of good records. Fernie, George // GP: General Practitioner;4/10/2009, p46 

    The article offers information in treating Alzheimer's disease among elderly people in Great Britain. Study shows that three cholinesterase inhibitors are efficient for mild-to-moderate Alzheimer's disease. Among these inhibitors are donepezil, galantamine and rivastigmine which were recommended...

  • Could oral health hold the key to curing Alzheimer's?  // Dental Nursing;Aug2009, Vol. 5 Issue 8, p427 

    The article focuses on the study, conducted by the British Dental Health Foundation (BDHF), which examined the relationship between oral health problems and Alzheimer's disease in Great Britain. Nigel Carter, chief executive officer (CEO) of the foundation, stated that the research of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics